{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:15:31Z","timestamp":1761894931123},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2009,7,30]],"date-time":"2009-07-30T00:00:00Z","timestamp":1248912000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.1007\/s12185-009-0386-2","type":"journal-article","created":{"date-parts":[[2009,7,29]],"date-time":"2009-07-29T06:35:12Z","timestamp":1248849312000},"page":"383-387","source":"Crossref","is-referenced-by-count":38,"title":["Chronic myeloid leukemia patient manifesting fatal hepatitis B virus reactivation during treatment with imatinib rescued by liver transplantation: case report and literature review"],"prefix":"10.1007","volume":"90","author":[{"given":"Byung Woog","family":"Kang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soo Jung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joon Ho","family":"Moon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shi-Nae","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yee Soo","family":"Chae","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jong Gwang","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoon-Jin","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sang-Kyun","family":"Sohn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,7,30]]},"reference":[{"key":"386_CR1","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1111\/j.1365-2141.2006.06465.x","volume":"136","author":"G Lalazar","year":"2007","unstructured":"Lalazar G, Rund D, Shouval D. Screening, prevention and treatment of viral hepatitis B reactivation in patients with haematological malignancies. Br J Haematol. 2007;136:699\u2013712.","journal-title":"Br J Haematol"},{"key":"386_CR2","doi-asserted-by":"publisher","first-page":"3147","DOI":"10.1182\/blood-2008-10-163493","volume":"113","author":"R Liang","year":"2009","unstructured":"Liang R. How I treat and monitor viral hepatitis B infection in patients receiving intensive immunosuppressive therapies or undergoing hematopoietic stem cell transplantation. Blood. 2009;113:3147\u201353.","journal-title":"Blood"},{"key":"386_CR3","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1183\/09031936.00025408","volume":"33","author":"JM Daniels","year":"2009","unstructured":"Daniels JM, Vonk-Noordegraaf A, Janssen JJ, Postmus PE, van AR. Tuberculosis complicating imatinib treatment for chronic myeloid leukaemia. Eur Respir J. 2009;33:670\u20132.","journal-title":"Eur Respir J"},{"key":"386_CR4","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1038\/sj.leu.2403401","volume":"18","author":"K Cwynarski","year":"2004","unstructured":"Cwynarski K, Laylor R, Macchiarulo E, Goldman J, Lombardi G, Melo JV, et al. Imatinib inhibits the activation and proliferation of normal T lymphocytes in vitro. Leukemia. 2004;18:1332\u20139.","journal-title":"Leukemia"},{"key":"386_CR5","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1038\/sj.bjc.6601699","volume":"90","author":"W Yeo","year":"2004","unstructured":"Yeo W, Zee B, Zhong S, Chan PK, Wong WL, Ho WM, et al. Comprehensive analysis of risk factors associating with Hepatitis B virus (HBV) reactivation in cancer patients undergoing cytotoxic chemotherapy. Br J Cancer. 2004;90:1306\u201311.","journal-title":"Br J Cancer"},{"key":"386_CR6","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1097\/00004836-199010000-00015","volume":"12","author":"S Gupta","year":"1990","unstructured":"Gupta S, Govindarajan S, Fong TL, Redeker AG. Spontaneous reactivation in chronic hepatitis B: patterns and natural history. J Clin Gastroenterol. 1990;12:562\u20138.","journal-title":"J Clin Gastroenterol"},{"key":"386_CR7","first-page":"935","volume":"8","author":"MH Cohen","year":"2002","unstructured":"Cohen MH, Williams G, Johnson JR, Duan J, Gobburu J, Rahman A, et al. Approval summary for imatinib mesylate capsules in the treatment of chronic myelogenous leukemia. Clin Cancer Res. 2002;8:935\u201342.","journal-title":"Clin Cancer Res"},{"key":"386_CR8","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1056\/NEJM200104053441401","volume":"344","author":"BJ Druker","year":"2001","unstructured":"Druker BJ, Talpaz M, Resta DJ, Peng B, Buchdunger E, Ford JM, et al. Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. N Engl J Med. 2001;344:1031\u20137.","journal-title":"N Engl J Med"},{"key":"386_CR9","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1080\/14639230500236818","volume":"47","author":"K Ikeda","year":"2006","unstructured":"Ikeda K, Shiga Y, Takahashi A, Kai T, Kimura H, Takeyama K, et al. Fatal hepatitis B virus reactivation in a chronic myeloid leukemia patient during imatinib mesylate treatment. Leuk Lymphoma. 2006;47:155\u20137.","journal-title":"Leuk Lymphoma"},{"key":"386_CR10","first-page":"e86","volume":"49","author":"TJ Thia","year":"2008","unstructured":"Thia TJ, Tan HH, Chuah TH, Chow WC, Lui HF. Imatinib mesylate-related fatal acute hepatic failure in a patient with chronic myeloid leukaemia and chronic hepatitis B infection. Singapore Med J. 2008;49:e86\u20139.","journal-title":"Singapore Med J"},{"key":"386_CR11","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1111\/j.1440-1746.1998.tb00539.x","volume":"13","author":"YF Liaw","year":"1998","unstructured":"Liaw YF. Hepatitis viruses under immunosuppressive agents. J Gastroenterol Hepatol. 1998;13:14\u201320.","journal-title":"J Gastroenterol Hepatol"},{"key":"386_CR12","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1634\/stemcells.2005-0069","volume":"23","author":"S Appel","year":"2005","unstructured":"Appel S, Balabanov S, Brummendorf TH, Brossart P. Effects of imatinib on normal hematopoiesis and immune activation. Stem Cells. 2005;23:1082\u20138.","journal-title":"Stem Cells"},{"key":"386_CR13","first-page":"1133","volume":"31","author":"J Chen","year":"2007","unstructured":"Chen J, Schmitt A, Giannopoulos K, Chen B, Rojewski M, Dohner H, et al. Imatinib impairs the proliferation and function of CD4+CD25+ regulatory T cells in a dose-dependent manner. Int J Oncol. 2007;31:1133\u20139.","journal-title":"Int J Oncol"},{"key":"386_CR14","doi-asserted-by":"publisher","first-page":"6955","DOI":"10.4049\/jimmunol.181.10.6955","volume":"181","author":"N Larmonier","year":"2008","unstructured":"Larmonier N, Janikashvili N, LaCasse CJ, Larmonier CB, Cantrell J, Situ E, et al. Imatinib mesylate inhibits CD4+ CD25+ regulatory T cell activity and enhances active immunotherapy against BCR-ABL- tumors. J Immunol. 2008;181:6955\u201363.","journal-title":"J Immunol"},{"key":"386_CR15","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1182\/blood-2003-03-0975","volume":"103","author":"S Appel","year":"2004","unstructured":"Appel S, Boehmler AM, Grunebach F, Muller MR, Rupf A, Weck MM, et al. Imatinib mesylate affects the development and function of dendritic cells generated from CD34+ peripheral blood progenitor cells. Blood. 2004;103:538\u201344.","journal-title":"Blood"},{"key":"386_CR16","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1182\/blood-2003-12-4266","volume":"104","author":"AB Dietz","year":"2004","unstructured":"Dietz AB, Souan L, Knutson GJ, Bulur PA, Litzow MR, Vuk-Pavlovic S. Imatinib mesylate inhibits T-cell proliferation in vitro and delayed-type hypersensitivity in vivo. Blood. 2004;104:1094\u20139.","journal-title":"Blood"},{"key":"386_CR17","first-page":"976","volume":"9","author":"GN Mattiuzzi","year":"2003","unstructured":"Mattiuzzi GN, Cortes JE, Talpaz M, Reuben J, Rios MB, Shan J, et al. Development of Varicella-Zoster virus infection in patients with chronic myelogenous leukemia treated with imatinib mesylate. Clin Cancer Res. 2003;9:976\u201380.","journal-title":"Clin Cancer Res"},{"key":"386_CR18","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1080\/13693780701558969","volume":"46","author":"M Speletas","year":"2008","unstructured":"Speletas M, Vyzantiadis TA, Kalala F, Plastiras D, Kokoviadou K, Antoniadis A, et al. Pneumonia caused by Candida krusei and Candida glabrata in a patient with chronic myeloid leukemia receiving imatinib mesylate treatment. Med Mycol. 2008;46:259\u201363.","journal-title":"Med Mycol"},{"issue":"Suppl 8","key":"386_CR19","first-page":"viii5","volume":"22","author":"D Gotthardt","year":"2007","unstructured":"Gotthardt D, Riediger C, Weiss KH, Encke J, Schemmer P, Schmidt J, et al. Fulminant hepatic failure: etiology and indications for liver transplantation. Nephrol Dial Transplant. 2007;22(Suppl 8):viii5\u20138.","journal-title":"Nephrol Dial Transplant"},{"key":"386_CR20","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1055\/s-2008-1073119","volume":"28","author":"IW Liou","year":"2008","unstructured":"Liou IW, Larson AM. Role of liver transplantation in acute liver failure. Semin Liver Dis. 2008;28:201\u20139.","journal-title":"Semin Liver Dis"},{"key":"386_CR21","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1097\/MOT.0b013e328300a352","volume":"13","author":"H Yeh","year":"2008","unstructured":"Yeh H, Olthoff KM. Live donor adult liver transplantation. Curr Opin Organ Transplant. 2008;13:241\u20136.","journal-title":"Curr Opin Organ Transplant"},{"key":"386_CR22","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1111\/j.1600-6143.2005.00915.x","volume":"5","author":"R Reding","year":"2005","unstructured":"Reding R. Is it right to promote living donor liver transplantation for fulminant hepatic failure in pediatric recipients? Am J Transplant. 2005;5:1587\u201391.","journal-title":"Am J Transplant"},{"key":"386_CR23","doi-asserted-by":"publisher","first-page":"22","DOI":"10.2152\/jmi.52.22","volume":"52","author":"M Shimada","year":"2005","unstructured":"Shimada M, Fujii M, Morine Y, Imura S, Ikemoto T, Ishibashi H. Living-donor liver transplantation: present status and future perspective. J Med Invest. 2005;52:22\u201332.","journal-title":"J Med Invest"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-009-0386-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12185-009-0386-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-009-0386-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-009-0386-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T05:01:27Z","timestamp":1559451687000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12185-009-0386-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7,30]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,10]]}},"alternative-id":["386"],"URL":"https:\/\/doi.org\/10.1007\/s12185-009-0386-2","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,7,30]]}}}